Synta Pharmaceuticals Corp. (NASDAQ:SNTA) today reported financial results for the fourth quarter and year ended December 31, 2013 and provided an update on recent corporate events.
“The team at Synta has made important progress with its two lead programs, ganetespib and the HDC platform,” said Keith Gollust, Chairman of the Executive Committee of Synta. “
Help employers find you! Check out all the jobs and post your resume.
